Published in Transpl Int on February 17, 2011
The Complement System and Antibody-Mediated Transplant Rejection. J Immunol (2015) 0.76
The Art of Compromise in Transfusion/Transplantation Medicine (and Some Parallels in Classical Literature). Transfus Med Hemother (2013) 0.75
Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10. Transplant Direct (2016) 0.75
Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection. J Immunol Res (2017) 0.75
Prediction of Long-term Renal Allograft Outcome By Early Urinary CXCL10 Chemokine Levels. Transplant Direct (2015) 0.75
Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis. Transplant Direct (2017) 0.75
Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med (2002) 5.34
Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant (2003) 4.54
Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57
Polyomavirus BK. Lancet Infect Dis (2003) 2.99
FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair. Nat Genet (2012) 2.74
Darbepoetin alpha in lower-than-equimolar doses maintains haemoglobin levels in stable haemodialysis patients converting from epoetin alpha/beta. Nephrol Dial Transplant (2007) 2.36
Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis (2008) 2.24
Influence of slide aging on results of translational research studies using immunohistochemistry. Mod Pathol (2004) 1.75
Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review. Transpl Int (2005) 1.65
C3 deposition glomerulopathy due to a functional factor H defect. Kidney Int (2008) 1.61
Tubular toxicity in sirolimus- and cyclosporine-based transplant immunosuppression strategies: an ancillary study from a randomized controlled trial. Am J Kidney Dis (2009) 1.53
Determinants of C1q binding in the single antigen bead assay. Transplantation (2014) 1.51
Late steroid withdrawal after ABO blood group-incompatible living donor kidney transplantation: high rate of mild cellular rejection. Transplantation (2010) 1.51
Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma. Am J Pathol (2003) 1.51
Human antiglomerular basement membrane autoantibody disease in XenoMouse II. Kidney Int (2002) 1.50
VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma. J Pathol (2002) 1.48
Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation (2009) 1.47
Computerized patient education in kidney transplantation: testing the content validity and usability of the Organ Transplant Information System (OTIS). Patient Educ Couns (2008) 1.42
Virtual slides: high-quality demand, physical limitations, and affordability. Hum Pathol (2003) 1.42
C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques. Nephrol Dial Transplant (2006) 1.40
E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Oncogene (2004) 1.40
Retroperitoneoscopic living donor nephrectomy: a retrospective comparison to the open approach. Transplantation (2004) 1.39
Lack of the transcriptional coactivator OBF-1 prevents the development of systemic lupus erythematosus-like phenotypes in Aiolos mutant mice. J Immunol (2003) 1.36
[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 is a highly efficient radiotherapeutic for glucagon-like peptide-1 receptor-targeted therapy for insulinoma. Clin Cancer Res (2007) 1.35
Examining assumptions regarding valid electronic monitoring of medication therapy: development of a validation framework and its application on a European sample of kidney transplant patients. BMC Med Res Methodol (2008) 1.32
Different types of microsatellite instability in ovarian carcinoma. Int J Cancer (2004) 1.30
Calretinin expression in human normal and neoplastic tissues: a tissue microarray analysis on 5233 tissue samples. Hum Pathol (2003) 1.29
CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. J Immunol (2009) 1.29
Cyclin E overexpression and amplification in human tumours. J Pathol (2003) 1.27
Tissue microarray analysis reveals prognostic significance of syndecan-1 expression in prostate cancer. Prostate (2003) 1.26
Factors to keep in mind when introducing virtual microscopy. Virchows Arch (2005) 1.24
Polyomavirus nephropathy in native kidneys and renal allografts: an update on an escalating threat. Transpl Int (2006) 1.24
Polyomavirus nephropathy: morphology, pathophysiology, and clinical management. Curr Opin Nephrol Hypertens (2003) 1.20
Expression patterns of potential therapeutic targets in prostate cancer. Int J Cancer (2005) 1.20
Targeted disruption of Col8a1 and Col8a2 genes in mice leads to anterior segment abnormalities in the eye. FASEB J (2005) 1.18
Supporting medication adherence in renal transplantation (SMART): a pilot RCT to improve adherence to immunosuppressive regimens. Clin Transplant (2006) 1.17
Multi-target fluorescence in situ hybridization in bladder washings for prediction of recurrent bladder cancer. Int J Cancer (2006) 1.15
HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsies. Int J Oncol (2004) 1.15
Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer. Oncogene (2002) 1.14
Kidney transplants, antibodies and rejection: is C4d a magic marker? Nephrol Dial Transplant (2003) 1.13
Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients. J Transl Med (2008) 1.13
Chemokine receptor CXCR3 mediates T cell recruitment and tissue injury in nephrotoxic nephritis in mice. J Am Soc Nephrol (2007) 1.11
Uromodulin is expressed in renal primary cilia and UMOD mutations result in decreased ciliary uromodulin expression. Hum Mol Genet (2010) 1.10
Epithelial growth factor receptor status in primary and recurrent ovarian cancer. Mod Pathol (2006) 1.09
Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology. Transplantation (2007) 1.07
Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids. Am J Physiol Renal Physiol (2010) 1.07
DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer. Clin Cancer Res (2002) 1.04
Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection. Transplantation (2011) 1.03
Long-term prognosis of diffuse proliferative glomerulonephritis associated with infection in adults. Nephrol Dial Transplant (2002) 1.03
Chyloretroperitoneum with secondary chylothorax after retroperitoneoscopic donor nephrectomy. Urology (2005) 1.01
Medication adherence assessment: high accuracy of the new Ingestible Sensor System in kidney transplants. Transplantation (2013) 1.01
Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer. Int J Cancer (2009) 1.00
TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Am J Pathol (2004) 1.00
HER-2 and TOP2A coamplification in urinary bladder cancer. Int J Cancer (2003) 0.99
Renal amyloidosis revisited: amyloid distribution, dynamics and biochemical type. Nephrol Dial Transplant (2011) 0.97
High-throughput flow cytometry purification of transduced progenitors expressing defined levels of vascular endothelial growth factor induces controlled angiogenesis in vivo. Stem Cells (2010) 0.96
Detection of HLA-antibodies prior to renal transplantation: prospects and limitations of new assays. Swiss Med Wkly (2008) 0.94
Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection. Transplantation (2009) 0.94
High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J Pathol (2003) 0.94
Acute renal failure on immune reconstitution in an HIV-positive patient with miliary tuberculosis. Clin Infect Dis (2004) 0.93
Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies. Transplantation (2008) 0.93
Urine cytology findings of polyomavirus infections. Adv Exp Med Biol (2006) 0.93
Haemolytic uraemic syndrome caused by factor H mutation: is single kidney transplantation under intensive plasmatherapy an option? Nephrol Dial Transplant (2009) 0.92
Contribution of early failure to outcome on peritoneal dialysis. Perit Dial Int (2008) 0.92
Heart rate variability and cardiac troponin I are incremental and independent predictors of one-year all-cause mortality after major noncardiac surgery in patients at risk of coronary artery disease. J Am Coll Cardiol (2003) 0.91
Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort. Eur J Epidemiol (2013) 0.91
Clinical consequences of non adherence to immunosuppressive medication in kidney transplant patients. Transpl Int (2008) 0.91
Risk factors for polyoma virus nephropathy. Nephrol Dial Transplant (2008) 0.91
The novel WD-repeat protein Morg1 acts as a molecular scaffold for hypoxia-inducible factor prolyl hydroxylase 3 (PHD3). J Biol Chem (2006) 0.89
Urinary-cell mRNA and acute kidney-transplant rejection. N Engl J Med (2013) 0.89
Fibrillary glomerulonephritis: early diagnosis associated with steroid responsiveness. Am J Kidney Dis (2002) 0.89
Urine erythrocyte morphology in patients with microscopic haematuria caused by a glomerulopathy. Pediatr Nephrol (2008) 0.88
Induction of aberrant vascular growth, but not of normal angiogenesis, by cell-based expression of different doses of human and mouse VEGF is species-dependent. Hum Gene Ther Methods (2013) 0.87
C4d-fixing capability of low-level donor-specific HLA antibodies is not predictive for early antibody-mediated rejection. Transplantation (2010) 0.87
Coagulation parameters after retransfusion of unwashed blood. J Arthroplasty (2006) 0.87
No effect of sirolimus for kaposi sarcoma in a renal transplant recipient. Transplantation (2006) 0.87
Plasma neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury in acute heart failure. Crit Care (2012) 0.86
Complications of retroperitoneoscopic living donor nephrectomy: single center experience after 164 cases. World J Urol (2008) 0.86
High-throughput tissue microarray analysis of CMYC amplificationin urinary bladder cancer. Int J Cancer (2005) 0.86
A recurrent fibronectin glomerulopathy in a renal transplant patient: a case report. Clin Transplant (2012) 0.86
Combined abdominal aortic aneurysm repair and coronary artery bypass: presentation of 13 cases and review of the literature. Ann Vasc Surg (2006) 0.86
Retroperitoneoscopic donor nephrectomy: donor outcome and complication rate in comparison with three different techniques. World J Urol (2006) 0.85